Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

Incorrect labeling prompts OTC medicine recall

The mishap means that patients don't have the correct information about side-effects, drug interactions, and active ingredients.

RB, formerly Reckitt Benckiser, has voluntarily recalled bottles of Mucinex, because the over-the-counter medication may not have the correct corresponding drug facts label on the back.

The products are correctly labeled on the front of the bottle and lists all active ingredients, the company said.

According to News for Shoppers, 1.5 million bottles are involved in the recall.

This mislabeling could cause the user to be unaware of side effects and/or risks associated with the ingestion of certain product ingredients which include Acetaminophen, Dextromethorphan, Guaifenesin, Phenylephrine, and/or Diphenhydramine.

The recall includes liquid bottles of Mucinex Fast-Max Night Time Cold &Flu, MucinexFast-Max Cold & Sinus, MucinexFast-Max Severe Congestion & Cough, and MucinexFast-Max Cold, Flu & Sore Throat.

FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?
Break out of the ordinary: see what’s new in life sciences packaging
<strong>At PACK EXPO Las Vegas, you’ll see machinery in action and new tech from 2,300 suppliers, collaborate with experts and explore transformative solutions. Join us in September to experience a breakthrough for life sciences products.</strong>
REGISTER NOW & SAVE!
Break out of the ordinary: see what’s new in life sciences packaging